Pluri (PLUR) Enterprise Value (2010 - 2025)
Pluri (PLUR) posted quarterly Enterprise Value of $481000.0 for Q4 2025, up 120.22% year-over-year from $218419.4 in Q4 2024, and down 53.12% quarter-over-quarter from $1.0 million in Q3 2025.
Pluri (PLUR) Enterprise Value (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Enterprise Value for 16 consecutive years, with $481000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Enterprise Value rose 120.22% year-over-year to $481000.0; the TTM figure through Dec 2025 stood at $481000.0 (up 120.22% YoY), while the FY2025 annual figure was -$14.6 million, up 40.66% from the prior year.
- Enterprise Value slipped to $481000.0 in Q4 2025 per PLUR's latest filing, from $1.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $1.7 million in Q3 2024 and bottomed at -$65.5 million in Q2 2021.
- Historically, Enterprise Value has averaged -$22.7 million across 5 years, with a median of -$17.2 million in 2021.
- On a YoY basis, Enterprise Value climbed as much as 148.58% in 2024 and fell as far as 765.53% in 2024.
- Pluri's Enterprise Value stood at -$19.7 million in 2021, then sank by 130.48% to -$45.5 million in 2022, then surged by 101.82% to $827000.0 in 2023, then sank by 387.67% to -$2.4 million in 2024, then surged by 120.22% to $481000.0 in 2025.
- Business Quant data shows PLUR's Enterprise Value at $481000.0 in Q4 2025, $1.0 million in Q3 2025, and -$14.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 2.12 Bn |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | -7.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 481,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | -14.64 Mn |
| Mar 31, 2025 | -3.95 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | -24.67 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | 827,000.00 |
| Sep 30, 2023 | -3.41 Mn |
| Jun 30, 2023 | -39.12 Mn |
| Mar 31, 2023 | 911,000.00 |
| Dec 31, 2022 | -45.47 Mn |
| Sep 30, 2022 | -46.59 Mn |
| Jun 30, 2022 | -54.51 Mn |
| Mar 31, 2022 | -23.35 Mn |
| Dec 31, 2021 | -19.73 Mn |
| Sep 30, 2021 | -61.28 Mn |
| Jun 30, 2021 | -65.55 Mn |
| Mar 31, 2021 | -47.37 Mn |